Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2011 1
2012 1
2014 2
2015 3
2016 2
2017 2
2018 1
2019 3
2020 2
2021 3
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis.
Nicolas SE, Bear MD, Kanaan AO, Coman OA, Dima L. Nicolas SE, et al. Am J Ther. 2023 Nov-Dec 01;30(6):e535-e542. doi: 10.1097/MJT.0000000000001678. Am J Ther. 2023. PMID: 37921681 Clinical Trial.
These identically designed, double-blind, vehicle-controlled phase 3 trials randomized 881 patients to roflumilast 0.3% cream or vehicle, applied once daily for 8 weeks. In DERMIS-1, the Investigator Global Assessment success rate was 42.4% with roflumilast 0.3% cream …
These identically designed, double-blind, vehicle-controlled phase 3 trials randomized 881 patients to roflumilast 0.3% cream or vehi …
Impact of Dietary Patterns in Inflammatory Bowel Disease Subtypes Versus Healthy Subjects: a Retrospective Cohort Study.
Preda CM, Istratescu D, Nitescu M, Manuc T, Manuc M, Stroie T, Catrinoiu M, Tieranu C, Meianu CG, Tugui L, Ciora CA, Louis E, Diculescu M. Preda CM, et al. Maedica (Bucur). 2023 Jun;18(2):174-181. doi: 10.26574/maedica.2023.18.2.174. Maedica (Bucur). 2023. PMID: 37588829 Free PMC article.
Conclusion:Diet patterns before the onset of the disease are similar in patients with Crohn's disease and patients with ulcerative colitis: increased consumption of sweetened beverages, processed and fatty meat, fried food, salt, store-bought ice cream, and mayonnaise, and …
Conclusion:Diet patterns before the onset of the disease are similar in patients with Crohn's disease and patients with ulcerative colitis: …
ISPD Catheter-related Infection Recommendations: 2023 Update.
Chow KM, Li PK, Cho Y, Abu-Alfa A, Bavanandan S, Brown EA, Cullis B, Edwards D, Ethier I, Hurst H, Ito Y, de Moraes TP, Morelle J, Runnegar N, Saxena A, So SW, Tian N, Johnson DW. Chow KM, et al. Perit Dial Int. 2023 May;43(3):201-219. doi: 10.1177/08968608231172740. Epub 2023 May 26. Perit Dial Int. 2023. PMID: 37232412 Free article.
A new target for the overall exit site infection rate should be no more than 0.40 episodes per year at risk. The recommendation about topical antibiotic cream or ointment to catheter exit site has been downgraded. New recommendations include clarified suggestion of exit si …
A new target for the overall exit site infection rate should be no more than 0.40 episodes per year at risk. The recommendation about topica …
Plant-Based Dairy Alternatives-A Future Direction to the Milky Way.
Plamada D, Teleky BE, Nemes SA, Mitrea L, Szabo K, Călinoiu LF, Pascuta MS, Varvara RA, Ciont C, Martău GA, Simon E, Barta G, Dulf FV, Vodnar DC, Nitescu M. Plamada D, et al. Foods. 2023 May 3;12(9):1883. doi: 10.3390/foods12091883. Foods. 2023. PMID: 37174421 Free PMC article. Review.
A multitude of sources can be used for development such as cereals, pseudocereals, legumes, nuts, and seeds to obtain food products such as vegetal milk, cheese, cream, yogurt, butter, and different sweets, such as ice cream, which have nearly similar nutritional pr …
A multitude of sources can be used for development such as cereals, pseudocereals, legumes, nuts, and seeds to obtain food products such as …
A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis.
Georgescu SR, Mitran CI, Mitran MI, Amuzescu A, Matei C, Tampa M. Georgescu SR, et al. J Pers Med. 2022 Sep 19;12(9):1540. doi: 10.3390/jpm12091540. J Pers Med. 2022. PMID: 36143325 Free PMC article.
The aim of our study was to evaluate the efficiency of sertaconazole 2% cream compared with other topical treatments in patients with SD. ...At 28 days since the beginning of the treatment, the sertaconazole regimen was associated with a significantly higher percentage of …
The aim of our study was to evaluate the efficiency of sertaconazole 2% cream compared with other topical treatments in patients with …
Are European marketed acyclovir 5% cream products similar? Comparison with EU and US reference product.
Miron DS, Rădulescu FȘ, Voicu VA, Mînea A, Cardot JM, Shah VP. Miron DS, et al. Drug Dev Ind Pharm. 2021 Jun;47(6):990-1000. doi: 10.1080/03639045.2021.1957921. Epub 2021 Jul 27. Drug Dev Ind Pharm. 2021. PMID: 34279163
OBJECTIVE: The aim was to perform a comparative evaluation of composition and in vitro release performance of multisource acyclovir 5% creams. SIGNIFICANCE: The outcome was analyzed in relation with the principles of the Topical drug Classification System (TCS). ...
OBJECTIVE: The aim was to perform a comparative evaluation of composition and in vitro release performance of multisource acyclovir 5% cr …
Rheological and in vitro release measurements of manufactured acyclovir 5% creams: confirming sensitivity of the in vitro release.
Miron DS, Rădulescu FȘ, Voicu VA, Mînea A, Cardot JM, Shah VP. Miron DS, et al. Pharm Dev Technol. 2021 Sep;26(7):779-787. doi: 10.1080/10837450.2021.1945625. Epub 2021 Jun 30. Pharm Dev Technol. 2021. PMID: 34165370
Previous evaluation of marketed acyclovir 5% creams using in vitro release testing (IVRT) and its correlation with the qualitative composition confirmed the discriminative characteristics of this methodology. ...
Previous evaluation of marketed acyclovir 5% creams using in vitro release testing (IVRT) and its correlation with the qualitative co …
Measurement of skin viscoelasticity: A non-invasive approach in allergic contact dermatitis.
Constantin MM, Bucur S, Serban ED, Olteanu R, Bratu OG, Constantin T. Constantin MM, et al. Exp Ther Med. 2020 Dec;20(6):184. doi: 10.3892/etm.2020.9314. Epub 2020 Oct 13. Exp Ther Med. 2020. PMID: 33101474 Free PMC article.
The skin viscoelasticity was determined for all subjects with Cutometer(), using the suction method, by performing a dynamic assessment of parameters before and after applying a moisturizing cream. The results indicate a decrease in the elasticity parameters in both groups …
The skin viscoelasticity was determined for all subjects with Cutometer(), using the suction method, by performing a dynamic assessment of p …
A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.
Hung IF, Yap DY, Yip TP, Zhang RR, To KK, Chan KH, Tang SC, Lui SL, Levin Y, Kochba E, Lau JY, Yuen MF, Chan TM, Yuen KY. Hung IF, et al. Clin Infect Dis. 2021 Jul 15;73(2):e304-e311. doi: 10.1093/cid/ciaa804. Clin Infect Dis. 2021. PMID: 32556176 Clinical Trial.
Eligible patients were randomly allocated (1:1:1) into 1 treatment group, topical imiquimod cream followed by ID HBVv (IMQ + ID); and 2 control groups: topical aqueous cream (placebo) followed by ID HBVv (AQ + ID) or topical aqueous cream followed by intramus …
Eligible patients were randomly allocated (1:1:1) into 1 treatment group, topical imiquimod cream followed by ID HBVv (IMQ + ID); and …
Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts.
Preda CM, Manuc T, Chifulescu A, Istratescu D, Louis E, Baicus C, Sandra I, Diculescu MM, Reenaers C, van Kemseke C, Nitescu M, Tieranu C, Popescu M, Tugui L, Andrei A, Ciora CA, Gherorghe IS, Manuc M. Preda CM, et al. Rev Esp Enferm Dig. 2020 Jun;112(6):440-447. doi: 10.17235/reed.2020.6552/2019. Rev Esp Enferm Dig. 2020. PMID: 32450704 Free article.
RESULTS: in the entire IBD cohort (Romanian + Belgian), a significantly increased consumption of sweets (OR 3.36 [95 % CI 1.6,7]), processed and high fat meat (OR 2.5 [95 % CI 1.4, 4.7], fried food (OR 9.5 [3.8, 23.6]), salt (OR 2.8 [1.5, 5.3]), ice cream (OR 3.25 [1.1, 9. …
RESULTS: in the entire IBD cohort (Romanian + Belgian), a significantly increased consumption of sweets (OR 3.36 [95 % CI 1.6,7]), processed …
24 results